Clopiogrel not beneficial in addition to ASA after lower extremity bypass

In this randomized trial of patients 2-4 days post lower extremity (below the knee) bypass surgery, they were randomized to ASA +/- clopidogrel. After 6-24 months of follow up, rates of graft occlusion, revascularization, or death were no different between the groups. Clopidogrel added to ASA did not confer any benefit to patients after lower extremity bypass surgery (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment